Performance of a polymer-based DNA chip platform in detection and genotyping of human papillomavirus in clinical samples

Journal of Clinical Microbiology

Volumn 47, Issue 5, 2009, Pages 1428-1435

  Schenk, T ^a,d   Brandstetter, T ^b   Zur Hausen, A ^a   Alt Morbe J ^c   Huzly, D ^a   Ruhe J ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c Laboratory for DNA Analytics   (Germany)

^d LADR GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOPSY; CONDYLOMA ACUMINATUM; DNA MICROARRAY; FEMALE; GENOTYPE; HUMAN; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; VERRUCA VULGARIS; WART VIRUS;

CERVIX UTERI; FEMALE; HUMANS; LARYNX; MOUTH; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; SENSITIVITY AND SPECIFICITY; SKIN;

HUMAN PAPILLOMAVIRUS;

EID: 66149101229     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02080-08     Document Type: Article

References (39)

1. An, H. J., K. R. Kim, I. S. Kim, D. W. Kim, M. H. Park, I. A. Park, K. S. Suh, E. J. Seo, S. H. Sung, J. H. Sohn, H. K. Yoon, E. D. Chang, H. I. Cho, J. Y. Han, S. R. Hong, and G. H. Ahn. 2005. Prevalence of human papillomavirus DNA in various histological subtypes of cervical adenocarcinoma: a population-based study. Mod. Pathol. 18:528-534.
2. An, H. J., N. H. Cho, S. Y. Lee, I. H. Kim, C. Lee, S. J. Kim, M. S. Mun, S. H. Kim, and J. K. Jeong. 2003. Correlation of cervical carcinoma and precancerous lesions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip microarray method. Cancer 97:1672-1680.
3. Bjerre, P., L. Silfverdal, L. Dillner, B. Hagmar, H. Edvardsson, J. Dillner, and A. Andersson-Ellström. 2008. A randomized trial of basing treatment on human papillomavirus and/or cytology results in low-grade cervical lesion triage. Am. J. Obstet. Gynecol. 199:24.e1-24.e7.
4. Bollmann, R., A. D. Varnai, A. Bankfalvi, and M. Bollmann. 2007. Risk-adapted multimodal laboratory cervical screening - Pap test of the future? Pathologe 28:334-338.
5. Bulkmans, N. W. J., J. Berkhof, S. Bulk, M. C. G. Bleeker, F. J. van Kemenade, L. Rozendaal, P. J. F. Snijders, and C. J. L. M. Meijer. 2007. High-risk HPV type-specific clearance rates in cervical screening. Br. J. Cancer 96:1419-1424. (Pubitemid 46685773)
6. Castellsagué, X., M. Díaz, S. de Sanjosé, N. Muñoz, R. Herrero, S. Franceschi, R. W. Peeling, R. Ashley, J. S. Smith, P. J. F. Snijders, C. J. L. M. Meijer, and F. X. Bosch. 2006. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J. Natl. Cancer Inst. 98:303-315.
7. Choi, Y. L., E. Y. Cho, J. H. Kim, S. J. Nam, Y. L. Oh, S. Y. Song, J. H. Yang, and D. S. Kim. 2007. Detection of human papillomavirus DNA by DNA chip in breast carcinomas of Korean women. Tumour Biol. 28:327-332.
8. Cutts, F. T., S. Franceschi, S. Goldie, X. Castellsague, S. de Sanjose, G. Garnett, W. J. Edmunds, P. Claeys, K. L. Goldenthal, D. M. Harper, and L. Markowitz. 2007. Human papillomavirus and HPV vaccines: a review. Bull. W. H. O. 85:649-732.
9. Harper, D. M., E. L. Franco, C. M. Wheeler, A. B. Moscicki, B. Romanowski, C. M. Roteli-Martins, D. Jenkins, A. Schuind, S. A. Costa Clemens, and G. Dubin on behalf of the HPV Vaccine Study Group. 2006. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet 367:1247-1255.
10. Hildesheim, A., R. Herrero, S. Wacholder, A. C. Rodriguez, D. Solomon, M. C. Bratti, J. T. Schiller, P. Gonzalez, G. Dubin, C. Porras, S. E. Jimenez, and D. R. Lowy for the Costa Rican HPV Vaccine Trial Group. 2007. Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial. JAMA 298:743-753.
11. Hoyer, H., C. Scheungraber, R. Kuehne-Heid, K. Teller, C. Greinke, S. Leistritz, B. Ludwig, M. Dürst, and A. Schneider. 2005. Cumulative 5-year diagnoses of CIN2, CIN3 or cervical cancer after concurrent high-risk HPV and cytology testing in a primary screening setting. Int. J. Cancer 116:136-143.
12. Hwang, T. S., J. K. Jeong, M. Park, H. S. Han, H. K. Choi, and T. S. Park. 2003. Detection and typing of HPV genotypes in various cervical lesions by HPV oligonucleotide microarray. Gynecol. Oncol. 90:51-56. (Pubitemid 37338075)
13. Kahng, J., and H. J. Lee. 2008. Clinical efficacy of HPV DNA chip test in the era of HPV vaccination: 1,211 cases, a single institution study. Korean J. Lab. Med. 28:70-78.
14. Kim, J. Y., J. K. Yoon, M. J. Citardi, P. S. Batra, and H. J. Roh. 2007. The prevalence of human papilloma virus infection in sinonasal inverted papilloma specimens classified by histological grade. Am. J. Rhinol. 21:664-669.
15. Kim, K. H., M. S. Yoon, Y. J. Na, C. S. Park, M. R. Oh, and W. C. Moon. 2006. Development and evaluation of a highly sensitive human papillomavirus genotyping DNA chip. Gynecol. Oncol. 100:38-43. (Pubitemid 41815047)
16. Kjaer, S. K., A. J. van den Brule, G. Paull, E. I. Svare, M. E. Sherman, B. L. Thomsen, M. Suntum, J. E. Bock, P. A. Poll, and C. J. Meijer. 2002. Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study. BMJ 325:572.
17. Kjaer, S. K., G. Breugelmans, C. Munk, J. Junge, M. Watson, and T. Iftner. 2008. Population-based prevalence, type- and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark. Int. J. Cancer 123:1864-1870.
18. Kleter, B., L. van Doorn, L. Schrauwen, A. Molijn, S. Sastrowijoto, J. ter Schegget, J. Lindeman, B. ter Harmsel, M. Burger, and W. Quint. 1999. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J. Clin. Microbiol. 37:2508-2517.
19. Lee, G. Y., S. M. Kim, S. Y. Rim, H. S. Choi, C. S. Park, and J. H. Nam. 2005. Human papillomavirus (HPV) genotyping by HPV DNA chip in cervical cancer and precancerous lesions. Int. J. Gynecol. Cancer 15:81-87.
20. Lee, H. S., K. M. Kim, S. M. Kim, Y. D. Choi, J. H. Nam, C. S. Park, and H. S. Choi. 2007. Human papillomavirus genotyping using HPV DNA chip analysis in Korean women. Int. J. Gynecol. Cancer 17:497-501.
21. Lehr, H.-P., M. Reimann, A. Brandenburg, G. Sulz, and H. Klapproth. 2003. Real-time detection of nucleic acid interactions by total internal reflection fluorescence. Anal. Chem. 75:2414-2420. (Pubitemid 36582827)
22. Li, R. Z., J. F. Shi, Q. Z. Zhou, R. F. Wu, N. Li, L. N. Wu, Y. Q. Zhou, Q. Wang, Z. H. Liu, B. Liu, and Y. L. Qiao. 2006. Evaluation of gene chip technology for high risk type human papillomavirus in cervical cancer screening. Zhonghua Yi Xue Za Zhi 86:307-311.
23. Liu, C. H., W. L. Ma, R. Shi, Y. Q. Ou, B. Zhang, and W. L. Zheng. 2003. Possibility of using DNA chip technology for diagnosis of human papillomavirus. J. Biochem. Mol. Biol. 36:349-353. (Pubitemid 37100924)
24. Luo, C. W., C. H. Roan, and C. J. Liu. 2007. Human papillomaviruses in oral squamous cell carcinoma and pre-cancerous lesions detected by PCR-based gene-chip array. Int. J. Oral Maxillofac. Surg. 36:153-158. (Pubitemid 46179149)
25. Menzo, S., K. Marinelli, P. Bagnarelli, S. Rolla, and M. Clementi. 2007. Human papillomavirus infections: new perspectives for prevention and treatment. New Microbiol. 30:189-212.
26. Muñoz, N., F. X. Bosch, X. Castellsagué, M. Díaz, S. de Sanjose, D. Hammouda, K. V. Shah, and C. J. Meijer. 2004. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int. J. Cancer 111:278-285. (Pubitemid 38924707)
27. Nuovo, G. J., D. Bartholomew, W. W. Jung, I. K. Han, T. Um, D. F. Grabarz, D. J. Lee, and R. T. McCabe. 2008. Correlation of Pap smear, cervical biopsy, and clinical follow-up with an HPV typing microarray system. Diagn. Mol. Pathol. 17:107-111.
28. Park, T. C., C. J. Kim, Y. M. Koh, K. H. Lee, J. H. Yoon, J. H. Kim, S. E. Namkoong, and J. S. Park. 2004. Human papillomavirus genotyping by the DNA chip in the cervical neoplasia. DNA Cell Biol. 23:119-125. (Pubitemid 38221929)
29. Perrons, C., R. Jelley, B. Kleter, W. Quint, and N. Brink. 2005. Detection of persistent high risk human papillomavirus infections with hybrid capture II and SPF10/LiPA. J. Clin. Virol. 32:278-285. (Pubitemid 40386560)
30. Qu, W., G. Jiang, Y. Cruz, C. J. Chang, G. Y. Ho, R. S. Klein, and R. D. Burk. 1997. PCR detection of human papillomavirus: comparison between MY09/ MY11 and GP5+/GP6+ primer systems. J. Clin. Microbiol. 35:1304-1310.
31. Rajan, S., T. H. Shen, J. Santhanam, N. H. Othman, N. Othman, and T. T. Hock. 2007. Comparison of DR. HPVtrade mark chip kit with hybrid capture II assay for the detection of human papillomavirus in clinical samples: a preliminary study. Trop. Biomed. 24:17-22.
32. Schiffmann, M., and D. Solomon. 2003. Findings to date from the ASCUS-LSIL triage study (ALTS). Arch. Pathol. Lab. Med. 127:946-949. (Pubitemid 36994853)
33. Schiffmann, M., P. E. Castle, J. Jeronimo, A. C. Rodriguez, and S. Wacholder. 2007. Human papillomavirus and cervical cancer. Lancet 370:890-907.
34. Smith, J. S., L. Lindsay, B. Hoots, J. Keys, S. Franceschi, R. Winer, and G. M. Clifford. 2007. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int. J. Cancer 121:621-632.
35. Villa, L. L., R. L. Costa, C. A. Petta, R. P. Andrade, J. Paavonen, O. E. Iversen, S. E. Olsson, J. Hoye, M. Steinwall, G. Riis-Johannessen, A. Andersson-Ellstrom, K. Elfgren, G. Krogh, M. Lehtinen, C. Malm, G. M. Tamms, K. Giacoletti, L. Lupinacci, R. Railkar, F. J. Taddeo, J. Bryan, M. T. Esser, H. L. Sings, A. J. Saah, and E. Barr. 2006. High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up. Br. J. Cancer 95:1459-1466.
36. Wang, D., L. Coscoy, M. Zylberberg, P. C. Avila, H. A. Boushey, D. Ganem, and J. L. DeRisi. 2002. Microarray-based detection and genotyping of viral pathogens. Proc. Natl. Acad. Sci. USA 99:15687-15692.
37. Wu, T. C. 2007. Therapeutic human papillomavirus DNA vaccination strategies to control cervical cancer. Eur. J. Immunol. 37:310-314. (Pubitemid 46915570)
38. zur Hausen, H. 2002. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer 2:342-350.
39. zur Hausen, H. 2000. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J. Natl. Cancer Inst. 92:690-698.